醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
LXEO · Lexeo Therapeutics, Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Lexeo Therapeutics, Inc.（LXEO）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $300K；高管董事有效買入 —、有效賣出 —。最近申報 2026-08-19。
買入 Bought—
賣出 Sold$300K
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-08-18 | Townsend Richard Nolan Chief Executive Officer, Director | 賣出 Sell | 3,345 | $4.95 | $17K | SEC |
| 2026-08-18 | Otero Jose Manuel Chief Operating Officer | 賣出 Sell | 1,304 | $4.96 | $6K | SEC |
| 2026-08-18 | Tamayo Louis Edward Chief Financial Officer | 賣出 Sell | 4,117 | $4.91 | $20K | SEC |
| 2026-07-01 | Bhalla Narinder Pal Chief Medical Officer | 賣出 Sell | 22,306 | $4.42 | $99K | SEC |
| 2026-07-01 | Townsend Richard Nolan Chief Executive Officer, Director | 賣出 Sell | 25,947 | $4.48 | $116K | SEC |
| 2026-07-01 | Otero Jose Manuel Chief Operating Officer | 賣出 Sell | 4,666 | $4.48 | $21K | SEC |
| 2026-07-01 | Tamayo Louis Edward Chief Financial Officer | 賣出 Sell | 4,641 | $4.49 | $21K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-08-18 | Tamayo Louis Edward Officer | 4,117 | $20K | |
| 2026-08-18 | Townsend Richard Nolan Officer, Director | 3,345 | $17K | |
| 2026-08-18 | Otero Jose Manuel Officer | 1,304 | $6K | |
| 2026-07-01 | Townsend Richard Nolan Officer, Director | 25,947 | $116K | |
| 2026-07-01 | Bhalla Narinder Pal Officer | 22,306 | $99K | |
| 2026-07-01 | Otero Jose Manuel Officer | 4,666 | $21K | |
| 2026-07-01 | Tamayo Louis Edward Officer | 4,641 | $21K |
內部人 Insiders
Townsend Richard Nolan、Otero Jose Manuel、Tamayo Louis Edward、Bhalla Narinder Pal